Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage

NCT02359162 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped The study is out of date

Conditions

Lymphoma, Extranodal NK-T-Cell

Interventions

DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Pegaspargase
DRUG: Etoposide
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Prednisone
RADIATION: IMRT

Sponsor

Sun Yat-sen University